Spectral Medical Stock Beta
SD4 Stock | EUR 0.35 0.01 2.78% |
SPECTRAL MEDICAL fundamentals help investors to digest information that contributes to SPECTRAL MEDICAL's financial success or failures. It also enables traders to predict the movement of SPECTRAL Stock. The fundamental analysis module provides a way to measure SPECTRAL MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SPECTRAL MEDICAL stock.
SPECTRAL |
SPECTRAL MEDICAL Company Beta Analysis
SPECTRAL MEDICAL's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current SPECTRAL MEDICAL Beta | 1.11 |
Most of SPECTRAL MEDICAL's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SPECTRAL MEDICAL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition |
In accordance with the recently published financial statements, SPECTRAL MEDICAL has a Beta of 1.1053. This is 28.52% higher than that of the Healthcare sector and 23.24% lower than that of the Diagnostics & Research industry. The beta for all Germany stocks is notably lower than that of the firm.
SPECTRAL Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SPECTRAL MEDICAL's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SPECTRAL MEDICAL could also be used in its relative valuation, which is a method of valuing SPECTRAL MEDICAL by comparing valuation metrics of similar companies.SPECTRAL MEDICAL is currently under evaluation in beta category among its peers.
SPECTRAL MEDICAL returns are very sensitive to returns on the market. As the market goes up or down, SPECTRAL MEDICAL is expected to follow.
SPECTRAL Fundamentals
Return On Equity | -7.84 | |||
Return On Asset | -0.74 | |||
Operating Margin | (6.38) % | |||
Shares Outstanding | 278.22 M | |||
Shares Owned By Insiders | 20.43 % | |||
Shares Owned By Institutions | 13.18 % | |||
Revenue | 1.66 M | |||
Gross Profit | 1.22 M | |||
EBITDA | (10.4 M) | |||
Net Income | (2.91 M) | |||
Cash And Equivalents | 3.43 M | |||
Cash Per Share | 0.01 X | |||
Debt To Equity | 14.70 % | |||
Current Ratio | 6.55 X | |||
Book Value Per Share | (0.01) X | |||
Cash Flow From Operations | (2.19 M) | |||
Earnings Per Share | (0.03) X | |||
Number Of Employees | 31 | |||
Beta | 1.11 | |||
Market Capitalization | 62.12 M |
About SPECTRAL MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SPECTRAL MEDICAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SPECTRAL MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SPECTRAL MEDICAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin | |
ADA | Cardano | |
XRP | XRP |
Other Information on Investing in SPECTRAL Stock
SPECTRAL MEDICAL financial ratios help investors to determine whether SPECTRAL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SPECTRAL with respect to the benefits of owning SPECTRAL MEDICAL security.